SMTL ID : 5o1a.1 (1 other biounit)

p53 cancer mutant Y220C in complex with compound MB240

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.44 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.83, H.86, C.145, C.149 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.83, A:H.86, A:C.145, A:C.149

1 x 9H5: [3,5-bis(iodanyl)-2-oxidanyl-4-pyrrol-1-yl-phenyl]-(4-methylpiperazin-1-yl)methanone(Non-covalent)

9H5.2: 11 residues within 4Å: Chain A: L.52, V.54, D.55, S.56, T.57, C.127, E.128, P.129, P.130, D.135, T.137 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.52, A:T.57, A:P.129 Hydrogen bonds: A:D.135 Water bridges: A:V.54 Halogen bonds: A:L.52

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Baud, M.G.J. et al., Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines. Eur J Med Chem (2018)

Release Date

2018-05-09

Peptides

Cellular tumor antigen p53: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cellular tumor antigen p53

Related Entries With Identical Sequence